Your Veeva Vault migration has a deadline. Your field doesn't have a downtime window.

Veeva Vault DevOps is the practice of managing, versioning, deploying, and governing configuration and metadata changes across Veeva Vault environments using controlled, auditable release pipelines instead of manual migrations. It brings version control, automated deployment, testing, rollback, and audit trails to Vault so life sciences teams can release faster while maintaining GxP control.

Veeva Vault does not provide native Git-based version control or one-click pipeline deployment. Configuration changes are moved between Vaults using Configuration Migration Packages (VPKs), Vault Compare reports, and MDL, and change tracking is largely manual — which is the gap dedicated DevOps tooling fills.

A Veeva Vault outbound Configuration Migration Package (VPK) is limited to 200 components per package. Larger or interdependent releases must be split into multiple packages and re-validated, and circular dependencies between components can produce a "Blocked" deployment status — a common source of manual rework that automated DevOps tooling manages for you.

Veeva CRM (the Salesforce-based product) reaches end of support on December 31, 2029—a deadline moved up from the originally planned September 2030 date. With Vault CRM now generally available, life sciences organizations must accelerate their migration plans between 2026 and 2029 to ensure uninterrupted, compliant operations.

The Veeva CRM to Vault CRM migration is Veeva's move of its CRM application off the Salesforce platform onto its own Vault Platform. It is a validated re-implementation — not a lift-and-shift — requiring data and configuration migration, integration rebuilds, and change management across both platforms until legacy Veeva CRM support ends on December 31, 2029.

Copado and Gearset are Salesforce DevOps tools; Copado's Veeva support targets Veeva CRM on the Salesforce platform, and Gearset is Salesforce-only. Neither offers DevOps for the Veeva Vault Platform's native configuration model, which is why dedicated Vault Platform tooling is required.

Flosum provides one governed change-management platform spanning both legacy Veeva CRM and the Veeva Vault Platform, so teams can run controlled, audited releases across both during the migration. This unified coverage lets organizations govern the entire CRM-to-Vault transition from a single system of record.

For 21 CFR Part 11, DevOps tooling should provide secure, computer-generated audit trails with user ID and timestamp, electronic-signature-backed approvals, access controls, and traceable change history for every configuration change. Flosum captures this evidence automatically for changes across Veeva Vault and Veeva CRM.

DevOps tooling supports GxP and GAMP 5 by enforcing a controlled, risk-based change lifecycle — specification, review, testing, approval, and traceable deployment — that produces the documentation needed to demonstrate a system stays in a validated state. GAMP 5 (Second Edition, 2022) explicitly encourages leveraging supplier tooling and evidence to reduce validation effort.

Computer Software Assurance (CSA) is the FDA's modernized, risk-based approach to computer system validation, recently finalized and aligned with the new QMSR. It emphasizes critical thinking and unscripted testing over exhaustive documentation for lower-risk functions. For DevOps tooling, CSA means you can scale your validation effort based on risk and rely heavily on vendor-provided evidence—drastically reducing the burden of qualifying the Flosum release platform itself.

You maintain an audit trail for AI-generated changes by routing every proposal from an AI agent through the same version control, review, and approval pipelines used for human developers. With Veeva AI Agents now active across Vault CRM and PromoMats, it is critical to ensure every automated action has a complete, immutable lineage. Flosum ensures that inspectors see reconstructable, compliant records, rather than just conversation logs.

Veeva Vault does not offer native Git-style branching or automated rollback of configuration; recovering from a bad change typically means manual re-migration. A metadata-aware DevOps platform adds true version history and reversible deployments, so you can roll back a Vault or Veeva CRM change to a known-good state.

A well-designed DevOps tool should reduce net validation effort, not add to it, by supplying supplier documentation, a controlled SDLC, and audit-ready change evidence you can leverage under a risk-based CSA/GAMP 5 approach. The validation burden of the tool itself is a key evaluation criterion — ask vendors for their qualification package and change-management/SDLC evidence up front.

Life sciences companies need DevOps during the migration because they must operate and change two live, regulated platforms simultaneously — legacy Veeva CRM and Vault — without losing audit control or missing the December 31, 2029 deadline. Governed pipelines across both platforms reduce migration risk, prevent uncontrolled changes, and provide the evidence auditors expect throughout the transition.

Metadata-aware version control tracks the specific configuration components and their dependencies — not just files — so it understands relationships between objects, fields, lifecycles, and workflows. For Veeva, this prevents the broken dependencies and manual reordering that plague 200-component VPK migrations and gives you a precise, reversible history of every change.